Cargando…

The effect of aldosterone and aldosterone blockade on the progression of chronic kidney disease: a randomized placebo-controlled clinical trial

The progression of chronic kidney disease (CKD) cannot be completely inhibited. We first explored factors contributing to CKD progression in patients with CKD in a prospective observational study. In the next phase, we focused on the effects of aldosterone, conducting a single-blinded placebo-contro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Minakuchi, Hitoshi, Wakino, Shu, Urai, Hidenori, Kurokochi, Arata, Hasegawa, Kazuhiro, Kanda, Takeshi, Tokuyama, Hirobumi, Itoh, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538950/ https://www.ncbi.nlm.nih.gov/pubmed/33024237 http://dx.doi.org/10.1038/s41598-020-73638-4

Ejemplares similares

NNMT activation can contribute to the development of fatty liver disease by modulating the NAD(+) metabolism
por: Komatsu, Motoaki, et al.
Publicado: (2018)

High Basolateral Glucose Increases Sodium-Glucose Cotransporter 2 and Reduces Sirtuin-1 in Renal Tubules through Glucose Transporter-2 Detection
por: Umino, Hiroyuki, et al.
Publicado: (2018)

The significance of NAD + metabolites and nicotinamide N-methyltransferase in chronic kidney disease
por: Takahashi, Rina, et al.
Publicado: (2022)

A Case Report of Autosomal Dominant Polycystic Kidney Disease Under Peritoneal Dialysis With Cyst Infection and Culture-Positive Peritoneal Fluid
por: Yasuda, Itaru, et al.
Publicado: (2019)

Ghrelin Protects against Renal Damages Induced by Angiotensin-II via an Antioxidative Stress Mechanism in Mice
por: Fujimura, Keiko, et al.
Publicado: (2014)

Obesity-induced kidney injury is attenuated by amelioration of aberrant PHD2 activation in proximal tubules
por: Futatsugi, Koji, et al.
Publicado: (2016)

Oral adsorbent AST-120 ameliorates gut environment and protects against the progression of renal impairment in CKD rats
por: Yoshifuji, Ayumi, et al.
Publicado: (2018)

Home‐based aerobic exercise and resistance training for severe chronic kidney disease: a randomized controlled trial
por: Uchiyama, Kiyotaka, et al.
Publicado: (2021)

Sirtuin and metabolic kidney disease
por: Wakino, Shu, et al.
Publicado: (2015)

Diabetic condition induces hypertrophy and vacuolization in glomerular parietal epithelial cells
por: Kawaguchi, Takahisa, et al.
Publicado: (2021)

Role of endogenous ACTH on circadian aldosterone rhythm in patients with primary aldosteronism
por: Sonoyama, Takuhiro, et al.
Publicado: (2014)

The role of aldosterone blockade in murine lupus nephritis
por: Monrad, Seetha U, et al.
Publicado: (2008)

Acute Interstitial Nephritis With Karyomegalic Epithelial Cells After Nivolumab Treatment—Two Case Reports
por: Ryuzaki, Masaki, et al.
Publicado: (2019)

Temporal trends in renal function and birthweight in Japanese adolescent males (1998–2015)
por: Kanda, Takeshi, et al.
Publicado: (2018)

Aldosterone and Its Blockade: A Cardiovascular and Renal Perspective
por: Lahera, V., et al.
Publicado: (2006)

Management of proteinuria: blockade of the renin–angiotensin–aldosterone system
por: Athavale, Akshay, et al.
Publicado: (2020)

Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension
por: Bioletto, Fabio, et al.
Publicado: (2023)

Dual Blockade of the Renin-angiotensin-aldosterone System in Type 2 Diabetic Kidney Disease
por: Feng, Yan-Huan, et al.
Publicado: (2016)

Masking by hypokalemia—primary aldosteronism with undetectable aldosterone
por: Boyle, Rebecca A, et al.
Publicado: (2020)

Quantitative Value of Aldosterone‐Renin Ratio for Detection of Aldosterone‐Producing Adenoma: The Aldosterone‐Renin Ratio for Primary Aldosteronism (AQUARR) Study
por: Maiolino, Giuseppe, et al.
Publicado: (2017)

Cardiovascular Risk Reduction with Renin-Angiotensin Aldosterone System Blockade
por: Houston Miller, Nancy
Publicado: (2010)

Aldosterone-Regulating Receptors and Aldosterone-Driver Somatic Mutations
por: Lim, Jung Soo, et al.
Publicado: (2021)

Aldosterone-producing adenoma is associated with urolithiasis in primary aldosteronism
por: Kang, Victor Jing-Wei, et al.
Publicado: (2023)

Gonadotropin-Releasing Hormone Stimulate Aldosterone Production in a Subset of Aldosterone-Producing Adenoma
por: Kishimoto, Rui, et al.
Publicado: (2016)

Treatment effects of renin-angiotensin aldosterone system blockade on kidney failure and mortality in chronic kidney disease patients
por: Vejakama, Phisitt, et al.
Publicado: (2017)

MPO-ANCA associated crescentic glomerulonephritis with numerous immune complexes: case report
por: Morizane, Ryuji, et al.
Publicado: (2012)

Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences
por: Lozano-Maneiro, Luz, et al.
Publicado: (2015)

Progress in the Management of Primary Aldosteronism
por: Morimoto, Ryo, et al.
Publicado: (2018)

Malignant Hypertension and Bilateral Primary Aldosteronism
por: Murai, Sayaka, et al.
Publicado: (2023)

Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure
por: Nappi, Jean M, et al.
Publicado: (2011)

Update on the Aldosterone Resolution Score and Lateralization in Patients with Primary Aldosteronism
por: Cho, Eun-Hee
Publicado: (2018)

Primary Aldosteronism: Metabolic Reprogramming and the Pathogenesis of Aldosterone-Producing Adenomas
por: Gong, Siyuan, et al.
Publicado: (2021)

Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease: Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade?
por: Brosnahan, Godela M., et al.
Publicado: (2018)

Comparison of 24-h Urinary Aldosterone Level and Random Urinary Aldosterone-to-Creatinine Ratio in the Diagnosis of Primary Aldosteronism
por: Wu, Che-Hsiung, et al.
Publicado: (2013)

Aldosterone, SGK1, and ion channels in the kidney
por: Valinsky, William C., et al.
Publicado: (2018)

Mitigating risk of aldosterone in diabetic kidney disease
por: Frimodt-Møller, Marie, et al.
Publicado: (2020)

Home-Based Exercise Program Ameliorates Renal Function Decline in Patients With CKD Stage 4
por: Adachi, Keika, et al.
Publicado: (2022)

Different pathogenesis of glucose intolerance in two subtypes of primary aldosteronism: Aldosterone‐producing adenoma and idiopathic hyperaldosteronism
por: Okazaki‐Hada, Mikiko, et al.
Publicado: (2020)

The Occurrence of Apparent Bilateral Aldosterone Suppression in Adrenal Vein Sampling for Primary Aldosteronism
por: Shibayama, Yui, et al.
Publicado: (2018)

Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism
por: Amar, Laurence, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_5cps07scbjpdp0j4m3ii954av9